Top compounds associated with response to CCL4L2


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.078 0.02
mRNA Fumonisin B1 CTRPv2 pan-cancer AAC 0.082 0.02
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.079 0.02
mRNA JQ-1 CTRPv2 pan-cancer AAC -0.069 0.03
mRNA Cyclopamine GDSC1000 pan-cancer AAC -0.12 0.03
mRNA CAL-101 GDSC1000 pan-cancer AAC 0.071 0.03
mRNA quizartinib CTRPv2 pan-cancer AAC -0.081 0.03
mRNA AZD-2281 CTRPv2 pan-cancer AAC 0.075 0.03
mRNA paclitaxel UHNBreast pan-cancer AAC -0.63 0.03
mRNA BX-912 GDSC1000 pan-cancer AAC -0.067 0.03
Download CSV